Hubert Gordian J, Müller-Barna Peter, Haberl Roman L
Department of Neurology and Neurological Intensive Medicine, Klinikum Harlaching, Städtisches Klinikum München GmbH, Thalkirchner Straße 48, 80337 Munich, Germany.
Int J Hypertens. 2013;2013:349782. doi: 10.1155/2013/349782. Epub 2013 Apr 23.
High blood pressure is common in acute stroke patients. Very high as well as very low blood pressure is associated with poor outcome. Spontaneous fall of blood pressure within the first few days after stroke was associated both with neurological improvement and impairment. Several randomized trials investigated the pharmacological reduction of blood pressure versus control. Most trials showed no significant difference in their primary outcome apart from the INWEST trial which found an increase of poor outcome when giving intravenous nimodipine. Nevertheless, useful information can be extracted from the published data to help guide the clinician's decision. Blood pressure should only be lowered when it is clearly elevated, and early after onset, reduction should be moderate but may be achieved rapidly. No clear recommendations can be given on the substances to use; however, care should be taken with intravenous calcium channel blockers and angiotensin receptor antagonists. Two ongoing randomized trials will help to solve the questions on blood pressure management in acute stroke.
高血压在急性中风患者中很常见。血压过高和过低都与预后不良有关。中风后最初几天内血压的自发下降与神经功能改善和损害都有关。几项随机试验研究了药物降压与对照的情况。除了INWEST试验外,大多数试验在主要结局上没有显著差异,INWEST试验发现静脉注射尼莫地平时不良结局增加。然而,可以从已发表的数据中提取有用信息来帮助指导临床医生的决策。只有在血压明显升高时才应降低血压,且在发病早期,降压应适度但可迅速实现。对于使用何种药物尚无明确建议;然而,应谨慎使用静脉钙通道阻滞剂和血管紧张素受体拮抗剂。两项正在进行的随机试验将有助于解决急性中风血压管理的问题。